When we discussed selegiline (Eldepryl - Britannia) in 1984,1 it was used simply to alleviate symptoms of Parkinson’s disease. Since then several studies have suggested that it may delay progression of the disease2,3 - controversial claims publicised in newspapers. What is the place of selegiline in the management of Parkinson’s disease?
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.